Agreement To Share Vaccine

April 8th, 2021 by

[98] Us Department of Health and Human Services (HHS), “Trump Administration`s Operation Warp Speed Accelerates AstraZeneca COVID-19 Vaccine to be Available Beginning in October, May 21, 2020, (available October 19, 2020). This means that, in many settings, vaccines will only be accessible and affordable to communities if they are free for care. Governments should attach conditions to their funding agreements to ensure that vaccines are able to deliver them to governments or international organizations at an affordable price that does not compromise their ability to meet their other social and economic rights obligations. International cooperation should aim to help governments ensure that they can distribute vaccines free of charge to groups of people who cannot afford to pay. Public authorities, particularly high-income countries,[50] invest a great deal of public funds in the research and development, production and distribution of Covid 19 vaccines. By mid-September 2020, they were at least $19.2 billion. [51] These governments have not disclosed the concrete details of their contracts or agreements. To put in place opportunities and mechanisms for civil society to participate meaningfully and sustainably in all global vaccine access initiatives. Publication of reports on civil society consultations and meetings. “Sister Noor” works in a unit exclusively for Covid 19 patients at a state hospital in Karachi, Pakistan. She told Human Rights Watch in May 2020, “We are in direct and constant contact with patients all day, taking DEIV lines or a blood sample, checking their blood pressure or giving them medication.” She lamented the quality of nurses kept for personal protective equipment (PEP) and added: “Our caps will tear if we put them on, but the doctors` clothes and caps are much more stable.” It believed that there was an informal piracy order for good quality PPE, and wondered how and when vaccines would be distributed – if available: [140] The Aspen Institute, “How Can We Ensure Equitable Access to the COVID-19 Vaccine?”, Webinar with Fatima Hassan, Health Justice Initiative (HJI), and Priti Krishtel, Founder, I-MAK, July 16, 2020, (called October 19, 2020). [103] Bill Bostock, “After the French government`s outrage, Sanofi withdrew its promise to give the United States priority access to its coronavirus vaccine,” Business Insider, May 13, 2020, (called October 19, 2020). Governments should use their regulatory powers to maximize the production capacity and affordability of Covid-19-related drugs, including vaccines.

These include pricing provisions and mandatory licensing rules for all Covid 19 medical devices, including vaccines. Decisions made by governments will determine how quickly everyone – especially in low- and middle-income countries – can have access to a safe and effective vaccine at an affordable price, and whether it will be in time to protect their health and lives.

Comments are closed.